- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03708250
PilBouTox® Project: Button Battery Poisoning From Data Collected by French Poison Control Centres (PILBOUTOX)
April 27, 2023 updated by: University Hospital, Bordeaux
PilBouTox® Project: Prospective and Descriptive Study About Button Battery Poisoning Performed on Data Collected by French Poison Control Centres (PCC)
Button batteries are found in all householders and can be responsible for poisoning, in particular in children.
Unexpected complications and death in children who have ingested button battery have been published for over twenty years in medical literature.
There are many questions related to the treatment that remain unanswered, because some data are missing in previously published studies.
The main objective of this study is to precisely describe poisoning cases by button battery in order to propose a better management
Study Overview
Status
Completed
Conditions
Detailed Description
Button batteries are found in all householders and can be responsible for poisoning, in particular in children.
Unexpected complications and death in children who have ingested button battery have been published for over twenty years in medical literature.
The most serious cases are those related to the ingestion of button cells, especially in children, when the battery gets stuck in the esophagus.
Poison control centres, as well as addictovigilance centres, are regularly called upon for serious poisoning resulting in hospitalization, for which precisely description is most often missing or difficult to obtain and limits the efficiency of the management of these poisonings.
So there are many questions related to the treatment that remain unanswered, because some data are missing in previously published studies.
For example, in many cases, there is a lack of detail of initial symptoms, delays between symptoms and completion of further tests, follow-ups… A prospective and descriptive study about button battery poisoning performed on data collected by French PCC will be conducted between the 1st June of 2016 and the 31 May of 2018: any call in a PCC that occurred during the period studied and concerning an exposure to a button cell regardless of the route of exposure, the age of the patient, and its symptomatology will be included.
The following data will be taken : severe complication, need for surgery, length of hospital stay, death, risk factors concerning the battery (size, voltage), abnormalities at the first fibroscopy.
Study Type
Observational
Enrollment (Actual)
510
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Angers, France
- Centre Anti Poison
-
Lille, France
- Centre Anti Poison
-
Lyon, France
- Centre Anti Poison
-
Marseille, France
- Centre Anti Poison
-
Nancy, France
- Centre Anti Poison
-
Paris, France
- Centre Anti Poison
-
Strasbourg, France
- Centre Anti Poison
-
Toulouse, France
- Centre Anti Poison
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Anyone who calls for exposure to a button cell regardless of the route of exposure, the age of the patient, and its symptomatology.
Description
Inclusion Criteria:
Any call that occurred during the period studied in a Poison Control Centre and concerning an exposure to a button cell regardless of the route of exposure, the age of the patient, and its symptomatology.
Exclusion Criteria:
Animal cases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
occurrence of a serious complication
Time Frame: Baseline
|
occurrence of a serious complication
|
Baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Need for surgery
Time Frame: baseline
|
Need for surgery
|
baseline
|
|
Length of hospital stay
Time Frame: baseline
|
Length of hospital stay
|
baseline
|
|
Death
Time Frame: baseline
|
Death
|
baseline
|
|
Battery Size
Time Frame: baseline
|
Battery Size
|
baseline
|
|
Battery Voltage
Time Frame: baseline
|
Battery Voltage
|
baseline
|
|
Presence of Lying
Time Frame: baseline
|
Presence of Lying
|
baseline
|
|
Length of Insertion
Time Frame: baseline
|
Length of Insertion
|
baseline
|
|
Abnormalities at First Fibroscopy
Time Frame: baseline
|
Abnormalities at First Fibroscopy
|
baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2016
Primary Completion (Actual)
May 31, 2018
Study Completion (Actual)
May 31, 2018
Study Registration Dates
First Submitted
October 12, 2018
First Submitted That Met QC Criteria
October 12, 2018
First Posted (Actual)
October 17, 2018
Study Record Updates
Last Update Posted (Actual)
April 28, 2023
Last Update Submitted That Met QC Criteria
April 27, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CHUBX 2018/54
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Button Battery Poisoning
-
Tanta UniversityNot yet recruitingSyndesmotic Screw | Suture Button | Fixation | Ankle Syndesmotic DiastasisEgypt
-
Chinese PLA General HospitalActive, not recruitingMRI | Neuroplasticity | Microgravity | Repeatable Battery for the Assessment of Neuropsychological StatusChina
-
National Institute of Environmental Health Sciences...Health Canada; Danish Institute for Public Health; Indian and Northern Affairs...Completed
-
National Institute of Environmental Health Sciences...Completed
-
Sir Salimullah Medical College Mitford HospitalCompletedOrganophosphorus PoisoningBangladesh
-
Intermountain Health Care, Inc.Recruiting
-
University of EdinburghToxicology Society of BangladeshCompletedPesticide Poisoning | Anticholinesterase Insecticide PoisoningBangladesh
-
Intermountain Health Care, Inc.Enrolling by invitation
-
Rigshospitalet, DenmarkCompletedCarbon Monoxide Poisoning From Fire AccidentsDenmark
-
Amani Hassan Abdel-WahabWithdrawnOrganophosphorus Poisoning